|
Mutation Information
|
Mutation Site
|
L100I |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
efavirenz (EFV);nevirapine (NVP) |
|
Country
|
China |
Literature Information
|
PubMed PMID
|
32500372
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2020 |
|
Journal
|
Virus genes |
|
Title
|
Retrospective analysis of HIV-1 drug resistance mutations in Suzhou, China from 2009 to 2014. |
|
Author
|
Song Y,Hu J,He J,Dong C,Yuan Y,Li Y,Li R,Ya X |
|
Evidence
|
Two of the mutations, M230L and L100I, which confer a high level of resistance efavirenz (EFV) and nevirapine (NVP) used as NNRTIs for first-line antiretroviral therapy (ART), were detected in this study.
|
|
|
HIV Mutation Detail Information